Nadifloxacin | Interleukin Related interleukin-related.com

Product Name :
Nadifloxacin

Search keywords :
Nadifloxacin

drugId :
null

Target Vo:
Topoisomerase IV

Target Vo Short Name :
Topoisomerase IV

Moa_Name:
Bacterial DNA gyrase inhibitors

First Approval Country :
Japan

First Approval Date Filter:
1993

Origin Company_Name :

Active Company_Name :
Ferrer Internacional Sa

Active Indication_Name:
Folliculitis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PDK1 Antibody
Cathepsin B Antibody
Hsp70 1A Antibody (YA727): Hsp70 1A Antibody (YA727) is a non-conjugated and Mouse origined monoclonal antibody about 70 kDa, targeting to Hsp70 1A (1D9). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts